Milwaukee, WINCT06906887Now EnrollingIRB Ready

Esophageal Cancer Clinical Trial in Milwaukee, WI

Access cutting-edge esophageal cancer treatment through this phase 2 clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.

Sponsored by Medical College of Wisconsin

Quick Self-Assessment

See if you qualify for this Milwaukee location

Preparing your pre-screening questions…

Expert Care in Milwaukee

Access esophageal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related esophageal cancer treatment provided free

Apply for This Milwaukee Location

Check if you qualify for this esophageal cancer clinical trial in Milwaukee, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Milwaukee

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Milwaukee site if eligible
  4. 4Begin participation

About This Esophageal Cancer Study in Milwaukee

This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.

Sponsor: Medical College of Wisconsin

Who Can Participate

Inclusion Criteria

A potential study subject who meets all of the following inclusion criteria is eligible to participate in the study.
Age ≥ 18 years.
Stage II-IVb adenocarcinoma of the esophagus (if IVb, oligometastatic only, felt to be eligible for definitive dose CRT treatment by treating physician).
Currently receiving or have received induction chemotherapy and planned for definitive dose chemoradiation (+/- esophagectomy).
Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
Adequate hematologic function within 30 days prior to registration defined as follows:
Absolute Neutrophil Count ≥ 1,500/mcg
Hemoglobin ≥ 8 gm/dL
Platelets ≥ 100,000/mcL.
Adequate renal function within 30 days prior to registration, defined as a creatinine clearance of ≥ 50 ml/min as calculated by the Cockcroft-Gault equation.
Adequate hepatic function within 30 days prior to registration, defined as total bilirubin ≤ 1.5 x ULN a. Note: patients with known Gilbert Syndrome can have a total bilirubin \< 2.5 x upper limit of normal (ULN).
Female patients \<65 years of age and of childbearing potential must have a negative serum/urine pregnancy test within 14 days prior to study entry. A female not of childbearing potential is one who has undergone a hysterectomy, bilateral oophorectomy, tubal ligation, or who has had no menses for 12 consecutive months.
Patients of reproductive potential must agree to use effective contraception for the duration of study treatment. Effective contraception includes oral contraceptives, implantable hormonal contraception, double-barrier method, or intrauterine device.
Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.
Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria

A potential study subject who meets any of the following exclusion criteria is ineligible to participate in the study.
Age \< 18 years.
Extensive distant metastatic cancer, defined as \>5 metastases.
Recurrent esophageal cancer. a. Note: prior or concurrent malignancies are allowed if they do not impact the study's primary endpoint (i.e., treatment-associated toxicity).
Prior non-approved chemotherapy for the treatment of cancer.
Prior radiotherapy to the region of the study cancer that would result in an overlap of radiation therapy fields.
Women must not be pregnant or breast-feeding.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Milwaukee?

Yes, this clinical trial (NCT06906887) has an active research site in Milwaukee, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Esophageal Cancer Treatment Options in Milwaukee, WI

If you're searching for esophageal cancer treatment options in Milwaukee, WI, this clinical trial (NCT06906887) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Milwaukee research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced esophageal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all esophageal cancer clinical trials near you to find additional studies recruiting in your area.

More Esophageal Cancer Trials in Milwaukee, WI

See all esophageal cancer clinical trials recruiting in Milwaukee — not just this study.

Browse Esophageal Cancer Trials in Milwaukee →

Browse More Trials by Condition

Esophageal Cancer TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Milwaukee?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Milwaukee, WI